Primary |
Product Used For Unknown Indication |
49.2% |
Cough |
17.0% |
Respiratory Tract Congestion |
9.9% |
Nasopharyngitis |
4.8% |
Blood Pressure |
2.1% |
Hypertension |
2.1% |
Drug Abuse |
1.8% |
Increased Upper Airway Secretion |
1.6% |
Nasal Congestion |
1.6% |
Malaise |
1.4% |
Bronchitis |
1.1% |
Sinus Congestion |
1.1% |
Upper Respiratory Tract Infection |
1.1% |
Anxiety |
0.9% |
Back Pain |
0.7% |
Blood Cholesterol |
0.7% |
Chest Discomfort |
0.7% |
Hormone Replacement Therapy |
0.7% |
Hypersensitivity |
0.7% |
Sinus Disorder |
0.7% |
|
Blood Pressure Increased |
11.7% |
Epistaxis |
10.2% |
Vomiting |
10.2% |
Dizziness |
6.7% |
Hallucination |
5.7% |
Somnolence |
5.7% |
Headache |
4.9% |
Loss Of Consciousness |
4.6% |
Nausea |
4.6% |
Haemoptysis |
4.2% |
Feeling Abnormal |
3.9% |
Incorrect Drug Administration Duration |
3.9% |
Hypertension |
3.5% |
Syncope |
3.5% |
Drug Abuse |
3.2% |
Palpitations |
3.2% |
Dyspnoea |
2.8% |
Wrong Technique In Drug Usage Process |
2.8% |
Tachycardia |
2.5% |
Diarrhoea |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
26.5% |
Cough |
17.7% |
Respiratory Tract Congestion |
13.5% |
Chronic Obstructive Pulmonary Disease |
5.6% |
Nasopharyngitis |
5.6% |
Drug Use For Unknown Indication |
3.7% |
Allergy To Chemicals |
2.8% |
Dizziness |
2.8% |
Malaise |
2.8% |
Bronchitis |
2.3% |
Multiple Allergies |
2.3% |
Nasal Congestion |
2.3% |
Hypertension |
1.9% |
Productive Cough |
1.9% |
Respiratory Tract Infection |
1.9% |
Vasomotor Rhinitis |
1.9% |
Fatigue |
1.4% |
Headache |
1.4% |
Asthma |
0.9% |
Back Pain |
0.9% |
|
Epistaxis |
11.4% |
Syncope |
10.0% |
Drug Abuse |
7.1% |
Vomiting |
7.1% |
Blood Pressure Increased |
5.7% |
Convulsion |
4.3% |
Dizziness |
4.3% |
Faeces Discoloured |
4.3% |
Headache |
4.3% |
Incorrect Drug Administration Duration |
4.3% |
Loss Of Consciousness |
4.3% |
Nausea |
4.3% |
Palpitations |
4.3% |
Respiratory Tract Infection |
4.3% |
Speech Disorder |
4.3% |
Wheezing |
4.3% |
Blood Glucose Decreased |
2.9% |
Confusional State |
2.9% |
Diarrhoea |
2.9% |
Feeling Abnormal |
2.9% |
|
Concomitant |
Drug Use For Unknown Indication |
17.8% |
Product Used For Unknown Indication |
16.1% |
Chronic Obstructive Pulmonary Disease |
8.2% |
Asthma |
7.7% |
Pain |
7.5% |
Metastases To Bone |
5.8% |
Cough |
4.6% |
Hypertension |
3.8% |
Contraception |
3.4% |
Hypersensitivity |
2.7% |
Immune System Disorder |
2.7% |
Constipation |
2.6% |
Nausea |
2.6% |
Depression |
2.2% |
Gastrooesophageal Reflux Disease |
2.2% |
Supplementation Therapy |
2.2% |
Bronchitis |
2.1% |
Crohn's Disease |
1.9% |
Diabetes Mellitus |
1.9% |
Premenstrual Syndrome |
1.9% |
|
Pneumonia |
11.1% |
Death |
8.6% |
White Blood Cell Count |
7.4% |
Drug Ineffective |
6.2% |
Diarrhoea |
4.9% |
Dyspnoea |
4.9% |
Lung Neoplasm Malignant |
4.9% |
Pain |
4.9% |
Pulmonary Embolism |
4.9% |
Wheezing |
4.9% |
Chest Pain |
3.7% |
Dehydration |
3.7% |
Liver Function Test Abnormal |
3.7% |
Neoplasm Malignant |
3.7% |
Nervousness |
3.7% |
Product Quality Issue |
3.7% |
Subcutaneous Abscess |
3.7% |
Throat Irritation |
3.7% |
Tricuspid Valve Incompetence |
3.7% |
Vomiting |
3.7% |
|
Interacting |
Depression |
50.0% |
Anxiety |
33.3% |
Generalized Anxiety Disorder |
16.7% |
|
|